Univ.- Prof. Dr. med. Marion Subklewe
Univ.- Prof. Dr. med. Marion Subklewe
LMU - Klinikum der Universität München, Med. Klinik III
Verified email at med.uni-muenchen.de - Homepage
Cited by
Cited by
Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
K Inaba, S Turley, F Yamaide, T Iyoda, K Mahnke, M Inaba, M Pack, ...
The Journal of experimental medicine 188 (11), 2163-2173, 1998
Cytokine release syndrome
A Shimabukuro-Vornhagen, P Gödel, M Subklewe, HJ Stemmler, ...
Journal for immunotherapy of cancer 6 (1), 1-14, 2018
Structures of the human and Drosophila 80S ribosome
AM Anger, JP Armache, O Berninghausen, M Habeck, M Subklewe, ...
Nature 497 (7447), 80-85, 2013
Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion
J Engelmayer, M Larsson, M Subklewe, A Chahroudi, WI Cox, ...
The Journal of Immunology 163 (12), 6762-6768, 1999
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
C Münz, KL Bickham, M Subklewe, ML Tsang, A Chahroudi, MG Kurilla, ...
The Journal of experimental medicine 191 (10), 1649-1660, 2000
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
KH Metzeler, T Herold, M Rothenberg-Thurley, S Amler, MC Sauerland, ...
Blood 128 (5), 686-698, 2016
A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells
A Reddy, M Sapp, M Feldman, M Subklewe, N Bhardwaj
Blood, The Journal of the American Society of Hematology 90 (9), 3640-3646, 1997
The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3
MM Gaidt, TS Ebert, D Chauhan, K Ramshorn, F Pinci, S Zuber, F O’Duill, ...
Cell 171 (5), 1110-1124. e18, 2017
Advances in cancer immunotherapy 2019–latest trends
S Kruger, M Ilmer, S Kobold, BL Cadilha, S Endres, S Ormanns, ...
Journal of Experimental & Clinical Cancer Research 38 (1), 1-11, 2019
Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism
C Krupka, P Kufer, R Kischel, G Zugmaier, FS Lichtenegger, T Köhnke, ...
Leukemia 30 (2), 484-491, 2016
CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell–engaging antibody AMG 330
C Krupka, P Kufer, R Kischel, G Zugmaier, J Bögeholz, T Köhnke, ...
Blood 123 (3), 356-365, 2014
Dendritic Cells Cross-Present Latency Gene Products from Epstein-Barr Virus–Transformed B Cells and Expand Tumor-Reactive Cd8+ Killer T Cells
M Subklewe, C Paludan, ML Tsang, K Mahnke, RM Steinman, C Münz
The Journal of experimental medicine 193 (3), 405-412, 2001
Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab
T Köhnke, C Krupka, J Tischer, T Knösel, M Subklewe
Journal of hematology & oncology 8 (1), 1-5, 2015
Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or R-CHOP …
RU Trappe, D Dierickx, H Zimmermann, F Morschhauser, P Mollee, ...
Journal of Clinical Oncology 35 (5), 536-543, 2017
T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment
FM Schnorfeil, FS Lichtenegger, K Emmerig, M Schlueter, JS Neitz, ...
Journal of hematology & oncology 8 (1), 1-12, 2015
Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD
K Sebelin-Wulf, TD Nguyen, S Oertel, M Papp-Vary, RU Trappe, ...
Transplant immunology 17 (3), 203-210, 2007
Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus
M Subklewe, A Chahroudi, A Schmaljohn, MG Kurilla, N Bhardwaj, ...
Blood, The Journal of the American Society of Hematology 94 (4), 1372-1381, 1999
Recent developments in immunotherapy of acute myeloid leukemia
FS Lichtenegger, C Krupka, S Haubner, T Köhnke, M Subklewe
Journal of hematology & oncology 10 (1), 1-20, 2017
Features of human CD3+ CD20+ T cells
E Schuh, K Berer, M Mulazzani, K Feil, I Meinl, H Lahm, M Krane, ...
The Journal of Immunology 197 (4), 1111-1117, 2016
Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
S Haubner, F Perna, T Köhnke, C Schmidt, S Berman, C Augsberger, ...
Leukemia 33 (1), 64-74, 2019
The system can't perform the operation now. Try again later.
Articles 1–20